These are described in detail in the Methods section on page 453.
ReviewWorldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
Introduction
Infection by certain types of human papillomavirus (HPV) is recognised as a causal and necessary factor for cervical cancer.1, 2, 3 Cervical cancer represents the second most common malignancy in women around the world and contributes to 9·8% of all female cancers.4 Other tumours related to HPV, such as anal, vaginal, vulvar, penile, and oropharyngeal, represent an additional 0·7% of all cancer sites in both men and women, so that HPV is estimated to be responsible for 5·2% of all cancers worldwide.5 A cross-sectional evaluation of the HPV DNA prevalence in 13 countries estimated that 6·6% of women in the age-range 15–74 years with normal cytology are carriers of HPV DNA, with marked variation within and between world regions (range 1·4–25·6%).6 Therefore, HPV can be considered as the most common known sexually transmitted agent worldwide.
To allow further comparisons of prevalence, type, and age-distribution of HPV across world regions, published data from female populations participating in screening programmes or epidemiological studies were retrieved and pooled. Statistical models were built to adjust for confounding variables and to standardise results to allow comparability of HPV prevalence estimates worldwide.
Section snippets
Identification and eligibility of relevant studies
A systematic Medline search was done to identify all reports on HPV prevalence published from January, 1995, to January, 2005, using combinations of the following index terms: “Papovaviridae”, “Papillomavirus (human)”, “Cervix neoplasms (epidemiology OR virology OR prevention and control)”, “epidemiology”, “prevalence”, “DNA probes (HPV)”, “polymerase chain reaction”, “enzyme-linked immunosorbent assay”, “women/female”, and “population”. Relevant additional references cited in retrieved
Results
The table shows crude and adjusted HPV prevalence estimates in 157 879 women with normal cytology, stratified by 15 world regions. The largest sample consisted of European studies (44·4% of all study women), followed by studies from the Americas (16·3% and 9·2% for northern and Central/South America, respectively). Studies from Asia contributed 26·0% of all study participants, of whom half were from south-central Asia (Indian subcontinent). African studies contributed 3·9% of all study women.
Discussion
This large meta-analysis of 157 879 women with normal cytology derived from 78 published studies worldwide allowed us to produce the most precise, comprehensive, and comparable estimates of HPV prevalence to date. The results estimate that at any given point in time, 10·4% of women worldwide were positive for cervical HPV DNA. Prevalence of HPV was higher in less developed countries (15·5%) than more developed countries (10·0%), and was highest in women younger than 25 years old (16·9%),
Age-related prevalence
This meta-analysis confirms that HPV infection is most common in women younger than 25 years of age. However, a second peak of HPV prevalence is seen in women aged 45 years or older in all regions with the exception of Asia. The pattern was not consistent, however, because the turning point from a downward trend to an upward trend was observed after 54 years of age in Africa and Europe, but after 44 years of age in estimates from the Americas. This age-specific phenomenon observed in older
Search strategy and selection criteria
References (23)
- et al.
Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis
Lancet
(2005) - et al.
Comparative analysis of characteristics of women with cervical cancer in high- versus low-incidence regions
Gynecol Oncol
(2004) - et al.
Features of HPV infection among the healthy attendants of gynecological practice in St Petersburg, Russia
Cancer Lett
(1999) - et al.
The causal relation between human papillomavirus and cervical cancer
J Clin Pathol
(2002) Papillomaviruses and cancer: from basic studies to clinical application
Nat Rev Cancer
(2002)- et al.
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
J Pathol
(1999) - et al.
GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase
(2004) The global health burden of infection-associated cancers in the year 2002
Int J Cancer
(2006)- et al.
Prevalence of human papillomavirus infection and correlation with cervical lesions in Japanese women
J Obstet Gynaecol Res
(2004) - et al.
Recent developments in computer-assisted analysis of mixtures
Biometrics
(1998)